Yvette Meißner

1.3k total citations
38 papers, 718 citations indexed

About

Yvette Meißner is a scholar working on Rheumatology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Yvette Meißner has authored 38 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Rheumatology, 14 papers in Public Health, Environmental and Occupational Health and 11 papers in Immunology. Recurrent topics in Yvette Meißner's work include Rheumatoid Arthritis Research and Therapies (17 papers), Pregnancy and Medication Impact (13 papers) and Reproductive System and Pregnancy (8 papers). Yvette Meißner is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (17 papers), Pregnancy and Medication Impact (13 papers) and Reproductive System and Pregnancy (8 papers). Yvette Meißner collaborates with scholars based in Germany, France and United States. Yvette Meißner's co-authors include Alf Lamprecht, Anja Strangfeld, Yann Pellequer, A. Zink, Joachim Listing, Adrian Richter, Karin Rockwitz, Nathalie Ubrich, Britta Siegmund and W. Demary and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Annals of the Rheumatic Diseases and International Journal of Pharmaceutics.

In The Last Decade

Yvette Meißner

36 papers receiving 709 citations

Peers

Countries citing papers authored by Yvette Meißner

Since Specialization

Citations

This map shows the geographic impact of Yvette Meißner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvette Meißner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvette Meißner more than expected).

Fields of papers citing papers by Yvette Meißner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvette Meißner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvette Meißner. The network helps show where Yvette Meißner may publish in the future.

Co-authorship network of co-authors of Yvette Meißner

This figure shows the co-authorship network connecting the top 25 collaborators of Yvette Meißner. A scholar is included among the top collaborators of Yvette Meißner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvette Meißner. Yvette Meißner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative risk of incident malignancies in rheumatoid arthritis patients treated with Janus kinase inhibitors or bDMARDs: observational data from the German RABBIT register 2025 ·Annals of the Rheumatic Diseases ·Martin Schäfer, (unknown), Vera Zietemann, (unknown), Yvette Meißner, Adrian Richter, (unknown), Karin Rockwitz, Klaus Krüger, (unknown), Anne C. Regierer, Anja Strangfeld	4
2	Antirheumatic drugs in reproduction, pregnancy, and lactation: a systematic literature review informing the 2024 update of the EULAR recommendations 2025 ·Annals of the Rheumatic Diseases ·Andrea Pluma, (unknown), (unknown), Irene Cecchi, (unknown), Luis Fernando Pérez-García, (unknown), Axel Finckh, Yvette Meißner, Frauke Förger	4
3	Impact of DMARD treatment and systemic inflammation on all-cause mortality in patients with rheumatoid arthritis and interstitial lung disease: a cohort study from the German RABBIT register 2024 ·RMD Open ·(unknown), Vera Zietemann, Yvette Meißner, A. Zink, Andreas Krause, Hanns‐Martin Lorenz, C. Kneitz, (unknown), Anja Strangfeld	13
4	Rhekiss—The German Register for Child Wish and Pregnancies in Inflammatory Rheumatic Diseases 2024 ·Pharmacoepidemiology and Drug Safety ·Anja Strangfeld, Yvette Meißner, Anja Weiß, (unknown), A. Zink, (unknown), (unknown), Peer Aries, Xenofon Baraliakos, (unknown), Cornelia Glaser, Jörg Henes, Hanns‐Martin Lorenz, Matthias Schneider, (unknown), Christof Specker, Jutta Richter, Rebecca Fischer‐Betz	1
5	Role of rheumatoid arthritis registries worldwide: What have they taught us? 2024 ·Best Practice & Research Clinical Rheumatology ·Paul Studenic, Yvette Meißner, Lianne Kearsley‐Fleet, Diederik De Cock	2
6	Impact of systemic inflammation and disease activity on the incidence of interstitial lung disease in patients with rheumatoid arthritis – a nested case-control study within the German biologics register RABBIT 2024 ·Arthritis Research & Therapy ·(unknown), (unknown), Rieke Alten, Andreas Krause, Matthias Schneider, (unknown), Anja Strangfeld, Yvette Meißner	2
7	Risk of major adverse cardiovascular events in patients with rheumatoid arthritis treated with conventional synthetic, biologic and targeted synthetic disease-modifying antirheumatic drugs: observational data from the German RABBIT register 2023 ·RMD Open ·Yvette Meißner, Martin Schäfer, Katinka Albrecht, Joern Kekow, (unknown), Hans‐Peter Tony, Anja Strangfeld	34
8	Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studies 2023 ·Annals of the Rheumatic Diseases ·Teresa A. Simon, Lixian Dong, Samy Suissa, Kaleb Michaud, Sofia Pedro, Marc C. Hochberg, Maarten Boers, Johan Askling, Thomas Frisell, Anja Strangfeld, Yvette Meißner, Vadim Khaychuk, (unknown), Michael A. Maldonado	3
9	Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study 2023 ·Seminars in Arthritis and Rheumatism ·Teresa A. Simon, Samy Suissa, Maarten Boers, Marc C. Hochberg, Mary Lou Skovron, Johan Askling, Kaleb Michaud, Anja Strangfeld, Sofia Pedro, Thomas Frisell, Yvette Meißner, (unknown), Andres Gomez‐Caminero	10
10	Infection outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study 2023 ·Seminars in Arthritis and Rheumatism ·Teresa A. Simon, Samy Suissa, Mary Lou Skovron, Thomas Frisell, Johan Askling, Kaleb Michaud, Sofia Pedro, Anja Strangfeld, Yvette Meißner, Maarten Boers, (unknown), (unknown), Andres Gomez‐Caminero, Marc C. Hochberg	6
11	Pregnancy and neonatal outcomes in women with axial spondyloarthritis: pooled data analysis from the European Network of Pregnancy Registries in Rheumatology (EuNeP) 2022 ·Annals of the Rheumatic Diseases ·Yvette Meißner, Anja Strangfeld, Anna Moltó, Frauke Förger, Marianne Wallenius, N. Costedoat‐Chalumeau, (unknown), Marion Couderc, René‐Marc Flipo, G. Guettrot-Imbert, Isabell Haase, (unknown), (unknown), Christophe Richez, Jérémie Sellam, Anja Weiß, Astrid Zbinden, Rebecca Fischer‐Betz, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	14
12	Erkenntnisse zu Schwangerschaft und Stillzeit bei entzündlich rheumatischen Erkrankungen durch Beobachtungsdaten 2021 ·Zeitschrift für Rheumatologie ·Yvette Meißner, Anja Strangfeld	1
13	Pregnancy in women with psoriatic arthritis: A systematic literature review of disease activity and adverse pregnancy outcomes 2021 ·Seminars in Arthritis and Rheumatism ·Yvette Meißner, (unknown), Rebecca Fischer‐Betz, Anja Strangfeld	11
14	Response to: ‘Correspondence on ‘EULAR recommendations for a core data set for pregnancy registries in rheumatology” by De Cock et al 2020 ·Annals of the Rheumatic Diseases ·Yvette Meißner, Rebecca Fischer‐Betz, A. Zink, Anja Strangfeld	2
15	EULAR recommendations for a core data set for pregnancy registries in rheumatology 2020 ·Annals of the Rheumatic Diseases ·Yvette Meißner, Rebecca Fischer‐Betz, Laura Andréoli, N. Costedoat‐Chalumeau, Diederik De Cock, Radboud J. E. M. Dolhain, Frauke Förger, (unknown), Anna Moltó, Catherine Nelson‐Piercy, (unknown), Luigi Raio, S. C. Rodriguez-García, Savino Sciascia, Marianne Wallenius, Astrid Zbinden, A. Zink, Anja Strangfeld	34
16	European Network of Pregnancy Registers in Rheumatology (EuNeP)—an overview of procedures and data collection 2019 ·Arthritis Research & Therapy ·Yvette Meißner, Anja Strangfeld, N. Costedoat‐Chalumeau, Frauke Förger, (unknown), Anna Moltó, (unknown), Marianne Wallenius, Rebecca Fischer‐Betz	28
17	Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort 2017 ·Annals of the Rheumatic Diseases ·Yvette Meißner, Adrian Richter, Bernhard Manger, H-P Tony, (unknown), Joachim Listing, A. Zink, Anja Strangfeld	37
18	Alternative Drug Delivery Approaches for the Therapy of Inflammatory Bowel Disease 2007 ·Journal of Pharmaceutical Sciences ·Yvette Meißner, Alf Lamprecht	64
19	Nanoparticles in inflammatory bowel disease: Particle targeting versus pH-sensitive delivery 2006 ·International Journal of Pharmaceutics ·Yvette Meißner, Yann Pellequer, Alf Lamprecht	97
20	Low molecular weight heparin loaded pH-sensitive microparticles 2006 ·International Journal of Pharmaceutics ·Yvette Meißner, Nathalie Ubrich, (unknown), Philippe Maincent, Alf Lamprecht	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact